Learn about the global orphan drugs market through The Business Research Company, which provides information on orphan drugs market size, orphan drugs market drivers and restraints, orphan drugs market players, the COVID-19 impact on the orphan drugs market, and more.

The global orphan drugs market size is expected to grow from $140.40 billion in 2021 to $154.81 billion in 2022 at a compound annual growth rate (CAGR) of 10.3%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The orphan drugs market is expected to reach $229.71 billion in 2026 at a CAGR of 10.4%.

The rising prevalence of rare diseases is a key factor driving the growth of the orphan drugs market.

Request A Sample For The Global Orphan Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2823&type=smp

The orphan drugs market consists of sales of orphan drugs and related services that are used to treat rare diseases. An orphan drug is a pharmaceutical drug developed to treat patients suffering from rare diseases and would not make profit if developed commercially.

Global Orphan Drugs Market Segments Include:
By Therapy Area: Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales
By Drug Type: Biological, Non-Biological
By Disease Type: Oncology, Hematology, Neurology, Cardiovascular, Others
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the orphan drugs market in 2021.

Approval of biological orphan drugs for multiple indication act as a key trend driving the growth of the orphan drugs market. The biological drugs are used for treating rare diseases such as cancer with fewer side effects that have a high prevalence rate in the developed world.

TBRC’s orphan drugs market report covers:

Major Market Players: Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd, Amgen, Biogen, Bayer, Novartis AG, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc, Eli Lilly and Company, Alexion Pharmaceuticals, Shire, Novo Nordisk, AstraZeneca, Eisai, Daiichi Sankyo, Merck, Teva Pharmaceutical Industries, Actelion Pharmaceuticals Ltd., and Aegerion Pharmaceuticals.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Orphan Drugs Global Market Report 2022-Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides orphan drugs market overviews, analyses and forecasts market size, share, orphan drugs market players, orphan drugs market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s orphan drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Enzymes Global Market Report 2022

Gastrointestinal Drugs Global Market Report 2022

Gastric Cancer Drugs Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: